Components:
Method of action:
Treatment option:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 13.03.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Top 20 medicines with the same treatments:
Aids prevention of dental plaque formation. Aids the treatment and prevention of gingivitis. For the maintenance of oral hygiene. Promotes gingival healing following periodontal surgery. Management of recurrent oral ulceration. For the treatment of denture stomatitis and oral thrush.
For oromucosal use.
Adults, the elderly and children: To be used as required up to twice daily. Rinse the mouth thoroughly for about 1 minute with 10ml. The mouthwash should be expelled from the mouth after rinsing.
Prior to dental surgery: Rinse the mouth thoroughly with 10ml for 1 minute. The mouthwash should be expelled from the mouth after rinsing.
Treatment of gingivitis: A course of one month is recommended.
Treatment of denture stomatitis: Soak the denture(s) in solution for 15 minutes twice daily.
Treatment of oral ulceration and oral thrush: Treatment should be continued for 48 hours after clinical resolution.
Known hypersensitivity to the product or any of its components, especially in those with a history of possible 0.05% Glucodine W-related allergic reactions.
For oral use only. Keep away from the eyes and ears. If the solution comes into contact with the eyes, rinse well with water. Keep out of the reach and sight of children. Do not swallow. If symptoms persist, stop using and consult your doctor or dentist.
0.05% Glucodine W Mouthwash contains 0.05% Glucodine W. 0.05% Glucodine W is known to induce hypersensitivity, including generalised allergic reactions and anaphylactic shock. The prevalence of 0.05% Glucodine W hypersensitivity is not known, but available literature suggests this is likely to be very rare. 0.05% Glucodine W Mouthwash should not be administered to anyone with a potential history of an allergic reaction to a 0.05% Glucodine W-containing compound.
No or negligible influence.
Skin disorders
Frequency not known: Allergic skin reactions such as dermatitis, pruritus, erythema, eczema, rash, urticaria, skin irritation, and blisters.
Immune disorders
Frequency not known: Hypersensitivity including anaphylactic shock.
A superficial discolouration of the dorsum of the tongue may occur which disappears after discontinuation of treatment. Discolouration of the teeth and silicate or composite restorations may also occur. The discolouration is not permanent and may be prevented by brushing daily with conventional toothpaste prior to using the mouthwash and avoiding tannin-containing food and drinks. In some cases a professional prophylaxis (scaling and polishing) may be necessary to completely remove the stain.
Transient disturbances of taste and a burning sensation of the tongue may occur on initial use of the mouthwash but usually diminishes with continued use.
In cases where oral desquamation occurs it may be necessary to discontinue treatment.
Very occasionally, swelling of the parotid glands during use has been reported. If this happens stop using the product and the effect should go away.
In all cases spontaneous resolution has occurred on discontinuation of treatment.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Care Scheme at: www.mhra.gov.uk/yellowcard.
0.05% Glucodine W is poorly absorbed by the oral route; therefore systemic effects are unlikely even if large volumes are swallowed. However, gastric lavage followed by supportive measures may be used as appropriate.
A01A B03 - Stomatological preparations, antiinfectives for local oral treatment
0.05% Glucodine W digluconate is a bisbiguanide antiseptic and disinfectant, which is bactericidal or bacteriostatic against a wide range of gram negative and gram positive vegetative bacteria, yeasts, dermatophyte fungi and lipophilic viruses. The antimicrobial activity covers most of the important species occurring in the oral microflora.
Due to its cationic nature, 0.05% Glucodine W digluconate binds strongly to skin, mucosa and other tissues and is thus very poorly absorbed. No detectable blood levels have been found following oral use.
No data of relevance to the prescriber, which is additional to that included in other sections of the SPC.
Care 0.05% Glucodine W Antiseptic Mouthwash is incompatible with anionic agents which are often present in toothpastes. Therefore these should be used before the mouthwash, rinsing the mouth between applications, or at a different time of day.
Not applicable.
- A pilot study to evaluate the effectiveness of adjunctive use of two antimicrobial topical gels in chronic gingivitis
- Spectrophotometric analysis of the color stability of white mineral trioxide aggregate in contact with four different irrigating solutions - An in vitrostudy
- New Strategy of Reducing Biofilm Forming Bacteria in Oral Cavity by Bismuth Nanoparticles
- Methicillin-Resistant Staphylococcus epidermidisLineages in the Nasal and Skin Microbiota of Patients Planned for Arthroplasty Surgery
- Quercetin as an Auxiliary Endodontic Irrigant for Root Canal Treatment: Anti-Biofilm and Dentin Collagen-Stabilizing Effects In Vitro
- Biocide-Induced Emergence of Antibiotic Resistance in Escherichia coli
- Antibiofilm and Protein-Repellent Polymethylmethacrylate Denture Base Acrylic Resin for Treatment of Denture Stomatitis
- Antibacterial Effect of High-Purity Nisin Alone and in Combination with D-Amino Acids or Chlorhexidine in an Endodontic-Like Biofilm Model
- Usnic acid deteriorates acidogenicity, acidurance and glucose metabolism of Streptococcus mutansthrough downregulation of two-component signal transduction systems
- Mechanical Biocompatibility, Osteogenic Activity,and Antibacterial Efficacy of Calcium Silicate–Zirconia Biocomposites
- Nasal decolonization of Staphylococcus aureusand the risk of surgical site infection after surgery: a meta-analysis
- Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae
- Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore
- Evaluation of Topical Lysostaphin as a Novel Treatment for Instrumented Rhesus Macaques ( Macaca mulatta) Infected with Methicillin-Resistant Staphylococcus aureus
- Minimizing the aerosol-generating procedures in orthodontics in the era of a pandemic: Current evidence on the reduction of hazardous effects for the treatment team and patients
- Validation of Three Different Sterilization Methods of Tilapia Skin Dressing: Impact on Microbiological Enumeration and Collagen Content
- Surgical skin adhesive bond is safe and feasible wound closure method to reduce surgical site infection following minimally invasive colorectal cancer surgery
- Both Handwashing and an Alcohol-Based Hand Sanitizer Intervention Reduce Soil and Microbial Contamination on Farmworker Hands during Harvest, but Produce Type Matters
- Differential effects of two early life stress paradigms on cerebellar-dependent delay eyeblink conditioning
- Preparation and of PVA-based compositions with embedded silver, copper and zinc oxide nanoparticles and assessment of their antibacterial properties